Samir Soneji1, Nichole T Tanner2, Gerard A Silvestri3, Christopher S Lathan4, William Black5. 1. Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth, Lebanon, NH; Geisel School of Medicine at Dartmouth, Lebanon, NH; Norris Cotton Cancer Center, Lebanon, NH. Electronic address: samir.soneji@dartmouth.edu. 2. Medical University of South Carolina Thoracic Oncology Research Group and Division of Pulmonary Critical Care Medicine; Ralph H. Johnson Veterans Affairs Hospital and Health Equity and Rural Outreach Innovation Center, Charleston, SC. 3. Medical University of South Carolina Thoracic Oncology Research Group and Division of Pulmonary Critical Care Medicine. 4. Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA. 5. Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth, Lebanon, NH; Department of Radiology, Geisel School of Medicine at Dartmouth, Lebanon, NH; Department of Community and Family Medicine, Geisel School of Medicine at Dartmouth, Lebanon, NH; Geisel School of Medicine at Dartmouth, Lebanon, NH; Norris Cotton Cancer Center, Lebanon, NH.
Abstract
BACKGROUND: Black patients with lung cancer diagnosed at early stages-for which surgical resection offers a potential cure-experience worse overall survival than do their white counterparts. We undertook a population-based study to estimate the racial and ethnic disparity in death from competing causes and assessed its contribution to the gap in overall survival among patients with early-stage lung cancer. METHODS: We collected survival time data for 105,121 Hispanic, non-Hispanic Asian, non-Hispanic black, and non-Hispanic white patients with early-stage (IA, IB, IIA, and IIB) lung cancer diagnosed between 2004 and 2013 from the Surveillance, Epidemiology, and End-Results registries. We modeled survival time using competing risk regression and included as covariates sex, age at diagnosis, race/ethnicity, stage at diagnosis, histologic type, type of surgical resection, and radiation sequence. RESULTS: Adjusting for demographic, clinical, and treatment characteristics, non-Hispanic blacks experienced worse overall survival compared with non-Hispanic whites (adjusted hazard ratio [aHR], 1.05; 95% CI, 1.02-1.08), whereas Hispanics and non-Hispanic Asians experienced better overall survival (aHR, 0.93; 95% CI, 0.89-0.98; and aHR, 0.82; 95% CI, 0.79-0.86, respectively). Worse survival from competing causes of death, such as cardiovascular disease and other cancers-rather than from lung cancer itself-led to the disparity in overall survival among non-Hispanic blacks (adjusted relative risk, 1.07; 95% CI, 1.02-1.12). CONCLUSIONS: Narrowing racial and ethnic disparities in survival among patients with early-stage lung cancer will rely on more than just equalizing access to surgical resection and will need to include better management and treatment of smoking-related comorbidities and diseases.
BACKGROUND: Black patients with lung cancer diagnosed at early stages-for which surgical resection offers a potential cure-experience worse overall survival than do their white counterparts. We undertook a population-based study to estimate the racial and ethnic disparity in death from competing causes and assessed its contribution to the gap in overall survival among patients with early-stage lung cancer. METHODS: We collected survival time data for 105,121 Hispanic, non-Hispanic Asian, non-Hispanic black, and non-Hispanic white patients with early-stage (IA, IB, IIA, and IIB) lung cancer diagnosed between 2004 and 2013 from the Surveillance, Epidemiology, and End-Results registries. We modeled survival time using competing risk regression and included as covariates sex, age at diagnosis, race/ethnicity, stage at diagnosis, histologic type, type of surgical resection, and radiation sequence. RESULTS: Adjusting for demographic, clinical, and treatment characteristics, non-Hispanic blacks experienced worse overall survival compared with non-Hispanic whites (adjusted hazard ratio [aHR], 1.05; 95% CI, 1.02-1.08), whereas Hispanics and non-Hispanic Asians experienced better overall survival (aHR, 0.93; 95% CI, 0.89-0.98; and aHR, 0.82; 95% CI, 0.79-0.86, respectively). Worse survival from competing causes of death, such as cardiovascular disease and other cancers-rather than from lung cancer itself-led to the disparity in overall survival among non-Hispanic blacks (adjusted relative risk, 1.07; 95% CI, 1.02-1.12). CONCLUSIONS: Narrowing racial and ethnic disparities in survival among patients with early-stage lung cancer will rely on more than just equalizing access to surgical resection and will need to include better management and treatment of smoking-related comorbidities and diseases.
Authors: Mary Beth Landrum; Nancy L Keating; Elizabeth B Lamont; Samuel R Bozeman; Barbara J McNeil Journal: Cancer Date: 2011-11-09 Impact factor: 6.860
Authors: Nichole T Tanner; Mulugeta Gebregziabher; Chanita Hughes Halbert; Elizabeth Payne; Leonard E Egede; Gerard A Silvestri Journal: Am J Respir Crit Care Med Date: 2015-07-15 Impact factor: 21.405
Authors: Tené T Lewis; Susan A Everson-Rose; Lynda H Powell; Karen A Matthews; Charlotte Brown; Kelly Karavolos; Kim Sutton-Tyrrell; Elizabeth Jacobs; Deidre Wesley Journal: Psychosom Med Date: 2006 May-Jun Impact factor: 4.312
Authors: Manali I Patel; Ange Wang; Kristopher Kapphahn; Manisha Desai; Rowan T Chlebowski; Michael S Simon; Chloe E Bird; Giselle Corbie-Smith; Scarlett Lin Gomez; Lucile L Adams-Campbell; Michele L Cote; Marcia L Stefanick; Heather A Wakelee Journal: J Clin Oncol Date: 2015-12-23 Impact factor: 44.544
Authors: Katherine C Fuh; James J Java; John K Chan; Daniel S Kapp; Bradley J Monk; Robert A Burger; Robert C Young; David S Alberts; William P McGuire; Maurie Markman; Jeffrey Bell; Robert F Ozols; Deborah K Armstrong; Carol Aghajanian; Michael A Bookman; Robert S Mannel Journal: Gynecol Oncol Date: 2019-06-19 Impact factor: 5.482
Authors: Haiying Cheng; H Dean Hosgood; Lei Deng; Kenny Ye; Christopher Su; Janaki Sharma; Yuanquan Yang; Balazs Halmos; Roman Perez-Soler Journal: Clin Lung Cancer Date: 2019-07-17 Impact factor: 4.785
Authors: Norma E Farrow; Selena J An; Paul J Speicher; David H Harpole; Thomas A D'Amico; Jacob A Klapper; Matthew G Hartwig; Betty C Tong Journal: J Thorac Cardiovasc Surg Date: 2019-11-13 Impact factor: 5.209
Authors: Karen M Freund; Jennifer S Haas; Stephenie C Lemon; Karen Burns White; Nicole Casanova; Laura S Dominici; John K Erban; Rachel A Freedman; Ted A James; Naomi Y Ko; Amy M LeClair; Beverly Moy; Susan K Parsons; Tracy A Battaglia Journal: Cancer Date: 2019-08-26 Impact factor: 6.860
Authors: Yukiko Kunitomo; Brett Bade; Craig G Gunderson; Kathleen M Akgün; Alexandria Brackett; Lynn Tanoue; Lori A Bastian Journal: J Gen Intern Med Date: 2022-07-15 Impact factor: 6.473